ABH Healthcare Limited (NSE:ABH)
India · Delayed Price · Currency is INR 80.70
-4.20 (-4.95%)
At close: Sep 4, 2026
ABH Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 525.07 | 492.67 | 413.8 | 296.11 | 35 | |
Revenue Growth | 6.58% | 19.06% | 39.75% | 746.09% | - |
Cost of Revenue | 199.26 | 192.89 | 189.1 | 147.4 | 8.98 |
Gross Profit | 325.81 | 299.78 | 224.7 | 148.71 | 26.02 |
Selling, General & Admin | 5.92 | 3.96 | 3.1 | 2.28 | 0.15 |
Other Operating Expenses | 171.54 | 163.87 | 145.25 | 105.78 | 23.48 |
Operating Expenses | 201.32 | 188.87 | 165.77 | 123.64 | 24.35 |
Operating Income | 124.49 | 110.91 | 58.93 | 25.07 | 1.66 |
Interest Expense | -37.37 | -34.7 | -28 | -12.08 | -0.19 |
Interest & Investment Income | 0.79 | 0.43 | 0.09 | - | - |
Other Non Operating Income (Expenses) | -7.43 | -2.33 | -1.51 | -1.22 | -0.24 |
EBT Excluding Unusual Items | 80.49 | 74.3 | 29.51 | 11.77 | 1.23 |
Gain (Loss) on Sale of Assets | -1.18 | - | -7.43 | -0.19 | - |
Pretax Income | 79.31 | 74.3 | 22.08 | 11.58 | 1.23 |
Income Tax Expense | 22.91 | 20.83 | 5.52 | 4.46 | 0.38 |
Earnings From Continuing Operations | 56.39 | 53.47 | 16.56 | 7.12 | 0.85 |
Minority Interest in Earnings | 0.06 | -0.08 | - | - | - |
Net Income | 56.45 | 53.39 | 16.56 | 7.12 | 0.85 |
Net Income to Common | 56.45 | 53.39 | 16.56 | 7.12 | 0.85 |
Net Income Growth | 5.73% | 222.48% | 132.43% | 738.00% | - |
Shares Outstanding (Basic) | 8 | 8 | 8 | 7 | 6 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 7 | 6 |
Shares Change | - | - | 18.23% | 10.92% | - |
EPS (Basic) | 7.06 | 6.67 | 2.07 | 1.05 | 0.14 |
EPS (Diluted) | 7.05 | 6.67 | 2.07 | 1.05 | 0.14 |
EPS Growth | 5.64% | 222.48% | 97.09% | 653.53% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -61.67 | -11.01 | -132.55 | -32.19 | -204.87 |
Free Cash Flow Per Share | -7.71 | -1.38 | -16.57 | -4.76 | -33.59 |
Gross Margin | 62.05% | 60.85% | 54.30% | 50.22% | 74.34% |
Operating Margin | 23.71% | 22.51% | 14.24% | 8.47% | 4.75% |
Profit Margin | 10.75% | 10.84% | 4.00% | 2.41% | 2.43% |
Free Cash Flow Margin | -11.75% | -2.23% | -32.03% | -10.87% | -585.39% |
EBITDA | 148.17 | 131.77 | 76.18 | 40.48 | 2.37 |
EBITDA Margin | 28.22% | 26.75% | 18.41% | 13.67% | 6.78% |
D&A For EBITDA | 23.68 | 20.86 | 17.25 | 15.41 | 0.71 |
EBIT | 124.49 | 110.91 | 58.93 | 25.07 | 1.66 |
EBIT Margin | 23.71% | 22.51% | 14.24% | 8.47% | 4.75% |
Effective Tax Rate | 28.89% | 28.04% | 25.01% | 38.48% | 30.89% |
Revenue as Reported | 525.9 | 493.17 | 413.95 | 296.11 | 35 |
Advertising Expenses | 4.77 | 3.64 | 2.99 | 2.28 | 0.15 |